Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$10,000.00
Nov 15, 2018
For-profit organization
Youth-Green: Industrial Designer
917703
The goal is to provide companies in the food, cannabis and beverage industry with a viable economic and scalable option for their processing lines.
$147,000.00
Nov 7, 2018
For-profit organization
CANNABIS - Fermentation & Process Development for the Production of Prenylated Polyketides in a Microbial Production Platform
916377
Prenylated polyketides are a class of molecules with significant therapeutic potential that currently lack a scalable, consistent, and pure manufacturing method. This project aims to show improvements in production methods for these molecules using a novel, microbial production platform.
$500,000.00
Nov 1, 2018
For-profit organization
CANNABIS - Production of active ingredients from plants of the cannabaceae family.
919157
Development of effective methods for extracting cannabinoids from industrial hemp and cannabis and development of purification methods to obtain these different compounds at pharmaceutical purity levels.
$294,526.00
Oct 1, 2018
Understanding the Impact of Legal Cannabis Access on Health: A Large, Prospective Cohort Study of Canadians Obtaining Medical Cannabis Authorization
$405,451.00
Oct 1, 2018
Ecological Momentary Assessment of Simultaneous Cannabis and Alcohol Use
$263,925.00
Oct 1, 2018
"Smoking is better than taking pills": a longitudinal qualitative study of cannabis use and symptom management among people living with HIV
$875.00
Oct 1, 2018
Effect of inhaled vaporized cannabis on dynamic airway function, breathlessness and exercise intolerance in adults with advanced COPD: A randomized controlled trial
$192,645.00
Sep 4, 2018
For-profit organization
Design and Rearchitecture of Platforms to Improve the Efficacy of Cannabinoid Therapy Through Applied Machine Learning and Statistical Analysis
915438
Development of platforms to capture and analyze data regarding the efficacy of medical cannabis treatments (Cannabis Patient Manager, Analytics Web Portal) using machine learning and statistical analysis to inform evidence-based treatment protocols (Wellness Tracker).
$46,000.00
Sep 3, 2018
For-profit organization
Development of microchip device for quantitative analysis of key components of cannabis
911697
This project will develop a new detection platform technology for real-time cannabis analysis. It will offer world-wide cannabis users and growers significant data analysis within minutes.
$50,000.00
Sep 3, 2018
For-profit organization
Business Development project for creation of Cannabis Standard Formulary
914180
Cannabis Standard will be an evidence-based medical cannabis formulary based on best available evidence and expert advice. Cannabis Standard includes the formulary with detailed specifications, digital platform that produces the ACMPR-required Medical Document, and registry to capture real-world patient outcomes (quality of life and productivity data).